JP2022525102A5 - - Google Patents
Info
- Publication number
- JP2022525102A5 JP2022525102A5 JP2021554692A JP2021554692A JP2022525102A5 JP 2022525102 A5 JP2022525102 A5 JP 2022525102A5 JP 2021554692 A JP2021554692 A JP 2021554692A JP 2021554692 A JP2021554692 A JP 2021554692A JP 2022525102 A5 JP2022525102 A5 JP 2022525102A5
- Authority
- JP
- Japan
- Prior art keywords
- radiation
- peaks
- necessary
- xrpd pattern
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962817194P | 2019-03-12 | 2019-03-12 | |
| US62/817,194 | 2019-03-12 | ||
| PCT/US2020/022221 WO2020185983A1 (en) | 2019-03-12 | 2020-03-12 | Polymorphs of a cardiac troponin activator |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525102A JP2022525102A (ja) | 2022-05-11 |
| JP2022525102A5 true JP2022525102A5 (enExample) | 2023-03-22 |
Family
ID=70190163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021554692A Pending JP2022525102A (ja) | 2019-03-12 | 2020-03-12 | 心臓トロポニン活性化因子の多形 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220185791A1 (enExample) |
| EP (1) | EP3938042A1 (enExample) |
| JP (1) | JP2022525102A (enExample) |
| CN (1) | CN114025845A (enExample) |
| TW (1) | TWI857027B (enExample) |
| WO (1) | WO2020185983A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20200924A1 (es) | 2017-09-13 | 2020-09-14 | Amgen Inc | Compuestos de bisamida sustituida que activan el sarcomero cardiaco |
| SG11202109891WA (en) | 2019-03-12 | 2021-10-28 | Amgen Inc | Polymorphs and cocrystals of a cardiac troponin activator |
| AU2022239717A1 (en) | 2021-03-15 | 2023-11-02 | Maze Therapeutics, Inc. | Inhibitors of glycogen synthase 1 (gys1) and methods of use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| AU3192500A (en) * | 1999-03-16 | 2000-10-04 | C & C Research Laboratories | Substituted proline derivatives and medicinal compositions containing the same |
| TW200911787A (en) * | 2007-07-03 | 2009-03-16 | Astrazeneca Ab | New aza-bicyclohexane compounds useful as inhibitors of thrombin |
| SG11201507258PA (en) * | 2013-03-14 | 2015-10-29 | Amgen Inc | Heterocyclic compounds and their uses |
| PE20200924A1 (es) * | 2017-09-13 | 2020-09-14 | Amgen Inc | Compuestos de bisamida sustituida que activan el sarcomero cardiaco |
-
2020
- 2020-03-12 US US17/593,113 patent/US20220185791A1/en not_active Abandoned
- 2020-03-12 JP JP2021554692A patent/JP2022525102A/ja active Pending
- 2020-03-12 TW TW109108225A patent/TWI857027B/zh active
- 2020-03-12 CN CN202080034295.8A patent/CN114025845A/zh active Pending
- 2020-03-12 EP EP20717440.0A patent/EP3938042A1/en not_active Withdrawn
- 2020-03-12 WO PCT/US2020/022221 patent/WO2020185983A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI660956B (zh) | 調節蛋白質激酶之化合物的合成 | |
| JP2022525102A5 (enExample) | ||
| AU2014239995B2 (en) | Salt of omecamtiv mecarbil and process for preparing salt | |
| JP2022140559A (ja) | Ｒａｄ１９０１－２ｈｃｌの多形性形態 | |
| JP2022550374A (ja) | テルフェニル化合物の新規な塩 | |
| JP2018520205A (ja) | レンバチニブメシル酸塩の新規結晶形及びその製造方法 | |
| JP6830888B2 (ja) | Ｊａｋ阻害剤の硫酸水素塩の結晶形およびその製造方法 | |
| JP2015512942A5 (enExample) | ||
| TWI751998B (zh) | 結晶型化合物 | |
| TW200529850A (en) | Methods of preparing aripiprazole crystalline forms | |
| JP2011515370A (ja) | ４−アミノ−５−フルオロ−３−［５−（４−メチルピペラジン−１−イル）−１ｈ−ベンズイミダゾール−２−イル］キノリン−２（１ｈ）−オン乳酸塩の結晶形態及び２つの溶媒和物形態 | |
| JP2021518400A5 (enExample) | ||
| JP2012526808A5 (enExample) | ||
| JP2018501289A (ja) | ネラチニブマレイン酸塩の新規な結晶形及びその製造方法 | |
| KR102576930B1 (ko) | 제2철 말톨의 결정질 형태 | |
| JP2023530785A5 (enExample) | ||
| JP5710490B2 (ja) | （ｒ）−５−（（ｅ）−２−（ピロリジン−３−イルビニル）ピリミジンの合成および新規の塩形態 | |
| US20190202826A1 (en) | Phosphotidylinositol 3-Kinase Inhibitors | |
| JP2023521411A5 (enExample) | ||
| US20130096325A1 (en) | Polymorphic forms of lubiprostone | |
| CA3095922A1 (en) | Solid-state forms of abemaciclib, their use and preparation | |
| JP2024530315A (ja) | Ｂｃｌ－２阻害剤の固体形態、それらの調製方法及び使用方法 | |
| JP2024509276A5 (enExample) | ||
| JP2020503330A5 (enExample) | ||
| JP2017507914A (ja) | テノホビルの固体形態 |